These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 38835067)

  • 1. Associations of body composition parameters with postoperative outcome and perineural tumour invasion after oncological pancreatic resection.
    Mueller TC; Henselmann M; Reischl S; Jaeger C; Trefzer C; Demir IE; Friess H; Martignoni ME
    BMC Surg; 2024 Jun; 24(1):175. PubMed ID: 38835067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer.
    Guarneri G; Pecorelli N; Bettinelli A; Campisi A; Palumbo D; Genova L; Gasparini G; Provinciali L; Della Corte A; Abati M; Aleotti F; Crippa S; De Cobelli F; Falconi M
    Eur J Surg Oncol; 2024 May; 50(5):106848. PubMed ID: 36863915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic Cancer.
    Okumura S; Kaido T; Hamaguchi Y; Kobayashi A; Shirai H; Yao S; Yagi S; Kamo N; Hatano E; Okajima H; Takaori K; Uemoto S
    Ann Surg Oncol; 2017 Nov; 24(12):3732-3740. PubMed ID: 28871520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.
    Jang M; Park HW; Huh J; Lee JH; Jeong YK; Nah YW; Park J; Kim KW
    Eur Radiol; 2019 May; 29(5):2417-2425. PubMed ID: 30406311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma - analysis from SWOG S1505.
    Sohal DPS; Boutin RD; Lenchik L; Kim J; Beg MS; Wang-Gillam A; Wade JL; Guthrie KA; Chiorean EG; Ahmad SA; Lowy AM; Philip PA; Chang VT
    J Gastrointest Surg; 2024 Mar; 28(3):232-235. PubMed ID: 38445914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia and visceral obesity assessed by computed tomography are associated with adverse outcomes in patients with Crohn's disease.
    Grillot J; D'Engremont C; Parmentier AL; Lakkis Z; Piton G; Cazaux D; Gay C; De Billy M; Koch S; Borot S; Vuitton L
    Clin Nutr; 2020 Oct; 39(10):3024-3030. PubMed ID: 31980183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
    Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
    Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia assessed with DXA and CT increases the risk of perioperative complications in patients with gastrectomy.
    Kim M; Lee CM; Kang BK; Ha TK; Choi YY; Lee SJ
    Eur Radiol; 2023 Jul; 33(7):5150-5158. PubMed ID: 36637463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Sarcopenic Obesity on Long-Term Cancer Outcomes and Postoperative Complications After Gastrectomy for Gastric Cancer.
    Juez LD; Priego P; Bajawi M; Cuadrado M; Blázquez LA; Sánchez-Picot S; Galindo J; Blázquez J; Fernández-Cebrián JM; Botella-Carretero JI
    J Gastrointest Surg; 2023 Jan; 27(1):35-46. PubMed ID: 36324039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body composition is associated with postoperative complications in perihilar cholangiocarcinoma.
    Wang G; Mantas A; Heij LR; Al-Masri TM; Liu D; Heise D; Schmitz SM; Olde Damink SWM; Luedde T; Lang SA; Ulmer TF; Neumann UP; Bednarsch J
    Cancer Med; 2024 Jan; 13(1):e6878. PubMed ID: 38164056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body composition assessment by artificial intelligence can be a predictive tool for short-term postoperative complications in Hartmann's reversals.
    Suthakaran R; Cao K; Arafat Y; Yeung J; Chan S; Master M; Faragher IG; Baird PN; Yeung JMC
    BMC Surg; 2024 Apr; 24(1):111. PubMed ID: 38622633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A high visceral adipose tissue-to-skeletal muscle ratio as a determinant of major complications after pancreatoduodenectomy for cancer.
    Sandini M; Bernasconi DP; Fior D; Molinelli M; Ippolito D; Nespoli L; Caccialanza R; Gianotti L
    Nutrition; 2016; 32(11-12):1231-7. PubMed ID: 27261062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Sarcopenic Obesity on Failure to Rescue from Major Complications Following Pancreaticoduodenectomy for Cancer: Results from a Multicenter Study.
    Pecorelli N; Capretti G; Sandini M; Damascelli A; Cristel G; De Cobelli F; Gianotti L; Zerbi A; Braga M
    Ann Surg Oncol; 2018 Jan; 25(1):308-317. PubMed ID: 29116490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer.
    Griffin OM; Duggan SN; Ryan R; McDermott R; Geoghegan J; Conlon KC
    Pancreatology; 2019 Sep; 19(6):850-857. PubMed ID: 31362865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
    Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
    J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.
    Pecorelli N; Carrara G; De Cobelli F; Cristel G; Damascelli A; Balzano G; Beretta L; Braga M
    Br J Surg; 2016 Mar; 103(4):434-42. PubMed ID: 26780231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of preoperative sarcopenia in predicting postoperative complications and survival after pancreatoduodenectomy for pancreatic cancer.
    La Vaccara V; Cascone C; Coppola A; Farolfi T; Cammarata R; Emerenziani S; Coppola R; Caputo D
    Ann Ital Chir; 2023; 94():45-51. PubMed ID: 36810297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.